Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-044859
Filing Date
2023-12-14
Accepted
2023-12-14 16:10:35
Documents
44
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 481324
2 ex31-1.htm EX-31.1 19888
3 ex31-2.htm EX-31.2 19937
4 ex32-1.htm EX-32.1 9116
5 ex32-2.htm EX-32.2 8669
  Complete submission text file 0001493152-23-044859.txt   2962574

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pure-20231031.xsd EX-101.SCH 20597
7 XBRL CALCULATION FILE pure-20231031_cal.xml EX-101.CAL 30803
8 XBRL DEFINITION FILE pure-20231031_def.xml EX-101.DEF 111618
9 XBRL LABEL FILE pure-20231031_lab.xml EX-101.LAB 213241
10 XBRL PRESENTATION FILE pure-20231031_pre.xml EX-101.PRE 168971
38 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 324016
Mailing Address 771 JAMACHA ROAD #512 EL CAJON CA 92019
Business Address 771 JAMACHA ROAD #512 EL CAJON CA 92019 619-596-8600
PURE BIOSCIENCE, INC. (Filer) CIK: 0001006028 (see all company filings)

EIN.: 330530289 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-14468 | Film No.: 231487191
SIC: 2890 Miscellaneous Chemical Products